1 Min Read
Feb 26 (Reuters) - Akcea Therapeutics Inc:
* AKCEA REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR FOURTH QUARTER AND YEAR END 2017
* Q4 LOSS PER SHARE $0.35 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.